Article
It is easy to underestimate in good times the consequences of excessive debt and low liquidity when times are tough, however. Like anything else, moderation is the key.
Money Matters: How to invest during rising inflation
Money Matters: Informing your perspective on the bear market
Urology Times Money Matters: What you must do to survive down markets
Urology Times Money Matters: Annuity myths
UT Money Matters: Are REITs right for your portfolio?
UT Money Matters: Roth IRA conversions
NIAGARA: ctDNA analysis highlights durvalumab’s impact in MIBC
Nivolumab/ipilimumab continues to show improved survival, durable response in aRCC
Mixed results reported for nivolumab/ipilimumab in cisplatin-ineligible mUC
EV plus pembrolizumab doubles CR rate vs chemotherapy in la/mUC